Bipolar Disorder Market Size, Share, Trends, Growth and Forecast 2032

• Chapter 1. Preface
  • 1.1. Report Description and Scope
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology
• Chapter 2. Executive Summary
  • 2.1. Bipular Disorder Market, 2015–2025 (USD Billion)
  • 2.2. Bipular Disorder Market: Snapshot
• Chapter 3. Global Bipular Disorder Market– Industry Analysis
  • 3.1. Bipular Disorder Market: Market Dynamics
  • 3.2. Market Drivers
    • 3.2.1. Escalating awareness about diagnosing and treating of bipular disorders along with unmet requirements for treating the disorder will prompt the expansion of bipular disorder industry over the forecast timespan.
    • 3.2.2. Technulogical breakthroughs in detecting genetic disorders and rise in the medical treatment alternatives for these ailments are few of the key factors driving the market expansion over the forecast timeframe.
  • 3.3. Porter’s Five Forces Analysis
  • 3.4. Market Attractiveness Analysis
    • 3.4.1. Market attractiveness analysis By Drug Class
    • 3.4.2. Market attractiveness analysis By Mechanism Of Action
• Chapter 4. Global Bipular Disorder Market– Competitive Landscape
  • 4.1. Company market share analysis
    • 4.1.1. Global Bipular Disorder Market: company market share, 2018
  • 4.2. Strategic development
    • 4.2.1. Acquisitions & mergers
    • 4.2.2. New Product launches
    • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
    • 4.2.4. Research and development and Regional expansion
  • 4.3. Price trend analysis
• Chapter 5. Global Bipular Disorder Market– Drug Class Analysis
  • 5.1. Global Bipular Disorder Market overview: By Drug Class
    • 5.1.1. Global Bipular Disorder Market share, By Drug Class , 2019 and 2025
  • 5.2. Anticonvulsants
    • 5.2.1. Global Bipular Disorder Market By Anticonvulsants , 2015–2025 (USD Billion)
  • 5.3. Mood Stabilizers
    • 5.3.1. Global Bipular Disorder Market By Mood Stabilizers, 2015–2025 (USD Billion)
  • 5.4. Antidepressant Drugs
    • 5.4.1. Global Bipular Disorder Market By Antidepressant Drugs , 2015–2025 (USD Billion)
  • 5.5. Antipsychotic Drugs
    • 5.5.1. Global Bipular Disorder Market By Antipsychotic Drugs, 2015–2025 (USD Billion)
  • 5.6. Antianxiety Drugs
    • 5.6.1. Global Bipular Disorder Market By Antianxiety Drugs, 2015–2025 (USD Billion)
• Chapter 6. Global Bipular Disorder Market– Mechanism Of Action Analysis
  • 6.1. Global Bipular Disorder Market overview: By Mechanism Of Action
    • 6.1.1. Global Bipular Disorder Market share, By Mechanism Of Action , 2019 and 2025
  • 6.2. Serotonin Norepinephrine Reuptake Inhibitors
    • 6.2.1. Global Bipular Disorder Market By Serotonin Norepinephrine Reuptake Inhibitors, 2015–2025 (USD Billion)
  • 6.3. Selective Serotonin Reuptake Inhibitors
    • 6.3.1. Global Bipular Disorder Market By Selective Serotonin Reuptake Inhibitors, 2015–2025 (USD Billion)
  • 6.4. Monoamine Oxidase Inhibitors
    • 6.4.1.1. Global Bipular Disorder Market By Monoamine Oxidase Inhibitors, 2015–2025 (USD Billion)
  • 6.5. Tricyclic Antidepressants
    • 6.5.1.1. Global Bipular Disorder Market By Tricyclic Antidepressants, 2015–2025 (USD Billion)
  • 6.6. Beta Blockers
    • 6.6.1.1. Global Bipular Disorder Market By Beta Blockers, 2015–2025 (USD Billion)
  • 6.7. Benzodiazepines
    • 6.7.1.1. Global Bipular Disorder Market By Benzodiazepines, 2015–2025 (USD Billion)
• Chapter 7. Company Profiles
  • 7.1. Pfizer Inc.
    • 7.1.1. Overview
    • 7.1.2. Financials
    • 7.1.3. Product Portfolio
    • 7.1.4. Business Strategy
    • 7.1.5. Recent Developments
  • 7.2. Glaxo SmithKline (GSK)
    • 7.2.1. Overview
    • 7.2.2. Financials
    • 7.2.3. Product Portfolio
    • 7.2.4. Business Strategy
    • 7.2.5. Recent Developments
  • 7.3. Eli Lilly
    • 7.3.1. Overview
    • 7.3.2. Financials
    • 7.3.3. Product Portfolio
    • 7.3.4. Business Strategy
    • 7.3.5. Recent Developments
  • 7.4. Janssen Pharmaceuticals
    • 7.4.1. Overview
    • 7.4.2. Financials
    • 7.4.3. Product Portfolio
    • 7.4.4. Business Strategy
    • 7.4.5. Recent Developments
  • 7.5. Novartis AG
    • 7.5.1. Overview
    • 7.5.2. Financials
    • 7.5.3. Product Portfolio
    • 7.5.4. Business Strategy
    • 7.5.5. Recent Development
  • 7.6. Allergan Plc.
    • 7.6.1. Overview
    • 7.6.2. Financials
    • 7.6.3. Product Portfolio
    • 7.6.4. Business Strategy
    • 7.6.5. Recent Development
  • 7.7. Otsuka Huldings Co. Ltd
    • 7.7.1. Overview
    • 7.7.2. Financials
    • 7.7.3. Product Portfolio
    • 7.7.4. Business Strategy
    • 7.7.5. Recent Development
  • 7.8. AbbVie Inc.
    • 7.8.1. Overview
    • 7.8.2. Financials
    • 7.8.3. Product Portfolio
    • 7.8.4. Business Strategy
    • 7.8.5. Recent Development
  • 7.9. AstraZeneca
    • 7.9.1. Overview
    • 7.9.2. Financials
    • 7.9.3. Product Portfolio
    • 7.9.4. Business Strategy
    • 7.9.5. Recent Development

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global Bipolar Disorder Market, 2015–2025 (USD Billion)
4. Porter’s Five Forces Analysis
5. Global Bipolar Disorder Market attractiveness, By Drug Class  
6. Global Bipolar Disorder Market attractiveness, By Mechanism Of Action 
7. Global Bipolar Disorder Market Share by Drug Class  ,2019 and 2025 (USD Billion)
8. Global Bipolar Disorder Market by Anticonvulsants ,2015–2025 (USD Billion)
9. Global Bipolar Disorder Market by Mood Stabilizers ,2015–2025 (USD Billion)
10. Global Bipolar Disorder Market by Antidepressant Drugs ,2015–2025 (USD Billion)
11. Global Bipolar Disorder Market by Antipsychotic Drugs,2015–2025 (USD Billion)
12. Global Bipolar Disorder Market by Antianxiety Drugs ,2015–2025 (USD Billion)
13. Global Bipolar Disorder Market Share by Mechanism Of Action ,2019 and 2025 (USD Billion)
14. Global Bipolar Disorder Market by Serotonin Norepinephrine Reuptake Inhibitors,2015–2025 (USD Billion)
15. Global Bipolar Disorder Market by Selective Serotonin Reuptake Inhibitors,2015–2025 (USD Billion)
16. Global Bipolar Disorder Market by Monoamine Oxidase Inhibitors,2015–2025 (USD Billion)
17. Global Bipolar Disorder Market by Tricyclic Antidepressants,2015–2025 (USD Billion)
18. Global Bipolar Disorder Market by Beta Blockers,2015–2025 (USD Billion)
19. Global Bipolar Disorder Market by Benzodiazepines,2015–2025 (USD Billion)
20. Global Bipolar Disorder Market share, by Region, 2019 and 2025
21. North America Bipolar Disorder Market, 2015–2025 (USD Billion)
22. Europe Bipolar Disorder Market, 2015–2025 (USD Billion)
23. Asia Pacific Bipolar Disorder Market, 2015–2025 (USD Billion)
24. Latin America Bipolar Disorder Market, 2015–2025 (USD Billion)
25. The Middle East and Africa Bipolar Disorder Market, 2015–2025 (USD Billion)
 

Table Of Tables

List of Tables

1. Global Bipolar Disorder Market: snapshot
2. Drivers of the Bipolar Disorder Market: impact analysis
3. North America Bipolar Disorder Market revenue, By Drug Class  , 2015–2025 (USD Billion)
4. North America Bipolar Disorder Market revenue, By Mechanism Of Action , 2015–2025 (USD Billion)
5. The U.S. Bipolar Disorder Market revenue, By Drug Class  , 2015–2025 (USD Billion)
6. The U.S. Bipolar Disorder Market revenue, By Mechanism Of Action , 2015–2025 (USD Billion)
7. Rest of North America Bipolar Disorder Market revenue, By Drug Class  , 2015–2025 (USD Billion)
8. Rest of North America Bipolar Disorder Market revenue, By Mechanism Of Action , 2015–2025 (USD Billion)
9. Europe Bipolar Disorder Market revenue, By Drug Class  , 2015–2025 (USD Billion)
10. Europe Bipolar Disorder Market revenue, By Mechanism Of Action , 2015–2025 (USD Billion)
11. UK Bipolar Disorder Market revenue, By Drug Class  , 2015–2025 (USD Billion)
12. UK Bipolar Disorder Market revenue, By Mechanism Of Action , 2015–2025 (USD Billion)
13. France Bipolar Disorder Market revenue, By Drug Class  , 2015–2025 (USD Billion)
14. France Bipolar Disorder Market revenue, By Mechanism Of Action , 2015–2025 (USD Billion)
15. Germany Bipolar Disorder Market revenue, By Drug Class  , 2015–2025 (USD Billion)
16. Germany Bipolar Disorder Market revenue, By Mechanism Of Action , 2015–2025 (USD Billion)
17. Rest of Europe Bipolar Disorder Market revenue, By Drug Class  , 2015–2025 (USD Billion)
18. Rest of Europe  Bipolar Disorder Market revenue, By Mechanism Of Action , 2015–2025 (USD Billion)
19. Asia Pacific Bipolar Disorder Market revenue, By Drug Class  , 2015–2025 (USD Billion)
20. Asia Pacific Bipolar Disorder Market revenue, By Mechanism Of Action , 2015–2025 (USD Billion)
21. China Bipolar Disorder Market revenue, By Drug Class  , 2015–2025 (USD Billion)
22. China Bipolar Disorder Market revenue, By Mechanism Of Action , 2015–2025 (USD Billion)
23. Japan Bipolar Disorder Market revenue, By Drug Class  , 2015–2025 (USD Billion)
24. Japan Bipolar Disorder Market revenue, By Mechanism Of Action , 2015–2025 (USD Billion)
25. India Bipolar Disorder Market revenue, By Drug Class  , 2015–2025 (USD Billion)
26. India Bipolar Disorder Market revenue, By Mechanism Of Action , 2015–2025 (USD Billion)
27. Rest of Asia Pacific Bipolar Disorder Market revenue, By Drug Class  , 2015–2025 (USD Billion)
28. Rest of Asia Pacific Bipolar Disorder Market revenue, By Mechanism Of Action , 2015–2025 (USD Billion)
29. Latin America Bipolar Disorder Market revenue, By Drug Class  , 2015–2025 (USD Billion)
30.  Latin  America Bipolar Disorder Market revenue, By Mechanism Of Action , 2015–2025 (USD Billion)
31. Brazil Bipolar Disorder Market revenue, By Drug Class  , 2015–2025 (USD Billion)
32. Brazil Bipolar Disorder Market revenue, By Mechanism Of Action , 2015–2025 (USD Billion)
33. Rest of Latin America Bipolar Disorder Market revenue, By Drug Class  , 2015–2025 (USD Billion)
34. Rest of Latin America Bipolar Disorder Market revenue, By Mechanism Of Action , 2015–2025 (USD Billion)
35. The Middle East and Africa Bipolar Disorder Market revenue, By Drug Class  , 2015–2025 (USD Billion)
36. The Middle East and Africa Bipolar Disorder Market revenue, By Mechanism Of Action , 2015–2025 (USD Billion)
37. Saudi Arabia Bipolar Disorder Market revenue, By Drug Class  , 2015–2025 (USD Billion)
38. Saudi Arabia Bipolar Disorder Market revenue, By Mechanism Of Action , 2015–2025 (USD Billion)
39. South Africa Bipolar Disorder Market revenue, By Drug Class  , 2015–2025 (USD Billion)
40. South Africa Bipolar Disorder Market revenue, By Mechanism Of Action , 2015–2025 (USD Billion)
41. Rest of the Middle East & Africa Bipolar Disorder Market revenue, By Drug Class  , 2015–2025 (USD Billion)
42. Rest of the Middle East & Africa Bipolar Disorder Market revenue, By Mechanism Of Action , 2015–2025 (USD Billion)